Translational Neurodegeneration Impact Factor, Indexing, Ranking

Translational Neurodegeneration Impact Factor, Indexing, Ranking

Translational Neurodegeneration (TN) is a scholarly journal dedicated to publishing research in the field of Neuroscience, and Published by BioMed Central. and its abbreviation is Transl Neurodegener.


Translational Neurodegeneration Aim and Scope

Translational Neurodegeneration is an open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. By offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration creates a novel interface between the fields of basic, translational, and clinical research. It includes Parkinson's disease and movement disorders, Alzheimer's disease and other dementias, motor neuron disease and other neurodegenerative diseases.


Translational Neurodegeneration Details


Journal title Translational Neurodegeneration (TN)
Abbreviation Transl Neurodegener
Online ISSN 2047-9158
Publisher Name BioMed Central
Editor-in-chief Shengdi Chen, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China
Subject Category Neuroscience
Access type Logo of open access journals Open Access
Impact Factor 10.9
SJR 2.571
SNIP 2.072
Ranking 536
CiteScore 15.3
H-Index 54
Quartile Q1
Review Time 116 days
Status 🟢 Active
Abstracting and Indexing
Impact Factor List 2024

Who we are? Clarification: Journals Insights - Your Open Access Ally
F T L W E